Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04M Buy
8,598
+385
+5% +$47K 0.04% 409
2026
Q2
$931K Buy
8,213
+952
+13% +$94.4K 0.03% 418
2026
Q1
$683K Sell
7,261
-118
-2% -$11.8K 0.03% 462
2025
Q4
$729K Buy
7,379
+1,094
+17% +$106K 0.04% 407
2025
Q3
$533K Buy
6,285
+1,355
+27% +$107K 0.03% 491
2025
Q2
$336K Sell
4,930
-734
-13% -$46.5K 0.02% 629
2025
Q1
$343K Sell
5,664
-100
-2% -$6.97K 0.03% 543
2024
Q4
$398K Buy
5,764
+890
+18% +$63.4K 0.03% 436
2024
Q3
$322K Buy
4,874
+2,010
+70% +$128K 0.03% 443
2024
Q2
$174K Buy
2,864
+791
+38% +$44.8K 0.02% 546
2024
Q1
$118K Buy
2,073
+90
+5% +$5.4K 0.02% 583
2023
Q4
$117K Buy
+1,983
New +$112K 0.03% 483

Other funds holding INCY

GAMMA Investing's INCY Position: Q3 2026 in Review

GAMMA Investing increased its Incyte (INCY) stake by 4.7% in Q3 2026, buying an estimated $47K and bringing the position to 8,598 shares worth $1.04M. The position accounts for 0.04% of the portfolio, ranked #409.

GAMMA Investing first reported a position in INCY in Q4 2023 and has held it in 12 quarters since. 24 funds tracked by Wall St. Rank hold INCY as of Q3 2026.

  • GAMMA Investing held 8,598 shares of Incyte worth $1.04M as of Q3 2026.
  • GAMMA Investing bought 385 Incyte shares in Q3 2026, an estimated $47K.
  • Incyte made up 0.04% of GAMMA Investing's portfolio in Q3 2026, its #409 holding.
  • GAMMA Investing first reported a position in Incyte in Q4 2023 and has held it in 12 quarters since.
  • 24 funds tracked by Wall St. Rank held Incyte as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.